Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Cordis Corp. Receives FDA Clearance For ADROIT Guiding Catheter - Quick Facts

RELATED NEWS
Trade JNJ now with 

Cordis Corporation, part of the Johnson & Johnson Family of Companies (JNJ: Quote) announced that it has received clearance from the Food and Drug Administration or FDA of its latest innovation in guiding catheters: the ADROIT 6F Guiding Catheter.

The ADROIT Catheter's innovative hybrid braid wire technology not only enables the production of a guide catheter with the largest lumen size on the U.S. market, it also facilitates better control and back up support. In addition, the new innovative design incorporating a flexible distal segment and soft longer tip allows atraumatic placement and stability, the company stated.

Cordis said that the ADROIT Guiding Catheter provides a wide range of shapes, including extra back-up shapes and radial specific shapes to support treatment needs of various coronary anatomies.

Click here to receive FREE breaking news email alerts for Johnson & Johnson and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. said Monday that its fourth quarter profit rose 13% from last year, driven by strong sales of its iPhones and Mac computers. The company's quarterly earnings per share also came in above analysts' expectations as did its quarterly sales. At the same time, the company gave an upbeat revenue forecast for the current quarter, which includes the all important holiday season. Stocks moved notably higher over the course of the trading day on Monday, extending the strong upward move seen last Friday. The gains on the day continued the recent recovery by the markets, with the Nasdaq and the S&P 500 closing higher for the third consecutive session. While Republicans have largely tried to frame the upcoming midterm elections as a referendum on President Barack Obama, Sen. Ted Cruz, R-Tex., has joined the few offering guidance on what the GOP will do if it manages to retake control of the Senate.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.